Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition

1. González-Juanatey, J.R.
2. Almendro-Delia, M.
3. Cosín-Sales, J.
4. Bellmunt-Montoya, S.
5. Gómez-Doblas, J.J.
6. Riambau, V.
7. García-Moll, X.
8. García-Alegría, J.
9. Hernández, J.L.
10. Lozano, F.S.
11. Suarez Fernández, C.